Stay updated on ALXN1210 vs Eculizumab in PNH Clinical Trial
Sign up to get notified when there's something new on the ALXN1210 vs Eculizumab in PNH Clinical Trial page.

Latest updates to the ALXN1210 vs Eculizumab in PNH Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedAdded a Location section including California, Texas, Alberta, and Ontario, and updated the page revision to v3.3.3. Removed the HHS Vulnerability Disclosure item.SummaryDifference0.3%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check43 days agoChange DetectedPublications notes were updated to state that entries are automatically filled from PubMed and may not pertain to the study, and a Revision: v3.3.2 tag was added. The deletions were adjusted to reflect the same PubMed auto-fill wording, indicating this is a cosmetic update with no change to study data.SummaryDifference0.1%

- Check51 days agoChange DetectedAdded a new study site: Tainan, Taiwan, 70403. Removed the alternate listing 'Tainan City, Taiwan, 70403' to standardize the location naming.SummaryDifference0.2%

- Check65 days agoChange DetectedNo substantive changes to the study details or data were observed; only minor formatting/layout adjustments appear in the screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check94 days agoChange DetectedAdded a government funding lapse notice and current operating status guidance with a new v3.2.0 release; removed the old v3.1.0 tag.SummaryDifference3%

- Check101 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0.SummaryDifference0.1%

Stay in the know with updates to ALXN1210 vs Eculizumab in PNH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALXN1210 vs Eculizumab in PNH Clinical Trial page.